Not able to attend the Expert Roundtable Discussion in Paris? Access the on-demand webcast here. This interactive event features expert perspectives on current and emerging uses of BTK inhibitors for CLL and MCL. Topics include:
- Current and Emerging Roles for BTK Inhibitors in CLL/SLL and MCL
- Mechanisms and efficacy of currently available BTKis
- Development of resistance and intolerance to first- and second-generation BTKis
- Emerging reversible noncovalent BTKis
- Selecting and Sequencing BTK Inhibitor Therapy in R/R CLL/SLL and R/R MCL
- Case Challenges
- Clinical Pearls and Insights of key abstracts from ESMO 2022
